MINJUVI subst sèche 200 mg flac
7680680830017
CH-68083
L01FX12
07.16.1.
Reimbursement limitations:
MINJUVI.01a
Lymphome diffus à grandes cellules B (DLBCL) en rechute ou réfractaire en association avec le …
1 / 3
google
Details
- Product number
- 6808301
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: tafasitamabum 200 mg, natrii citras dihydricus corresp. natrium 7.4 mg, acidum citricum monohydricum, trehalosum dihydricum, polysorbatum 20, pro vitro.
Articles (1)
Minjuvi 200 mg, poudre pour solution à diluer pour perfusion
Puder
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
7.4 MG | Substance | HBESI |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 754.15
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2022
Authorization holder
Incyte Biosciences International
1110 Morges
Authorization information
- Swissmedic authorization number
- 68083
- Drug name
- Minjuvi, poudre pour solution à diluer pour perfusion
- Galenic form
- PULPI
- ATC Code
- L01FX12
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 22/03/2022
- Authorization expiration date
- 20/05/2030
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- MINJUVI subst sèche 200 mg flac
- Description (DE)
- MINJUVI Trockensub 200 mg Durchstf
- Market launch
- 22/03/2022
- Narcotic (BTM)
- No